Scarpa RM - Search Results

1

A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Rigatti P, Brausi M, Scarpa RM, Porru D, Schumacher H, Rizzi CA; MICTUS Study Group. Rigatti P, et al. Among authors: scarpa rm. Prostate Cancer Prostatic Dis. 2003;6(4):315-23. doi: 10.1038/sj.pcan.4500680. Prostate Cancer Prostatic Dis. 2003. PMID: 14663474 Clinical Trial.

2

Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement.

Porru D, Scarpa RM, Prezioso D, Bertaccini A, Rizzi CA; HOUSE Study Group. Porru D, et al. Among authors: scarpa rm. Prostate Cancer Prostatic Dis. 2005;8(1):45-9. doi: 10.1038/sj.pcan.4500763. Prostate Cancer Prostatic Dis. 2005. PMID: 15655566 Clinical Trial.

3

Aims and methods. LUTS suggestive of BPH.

Prezioso D, Scarpa RM, Zattoni F, Viaggi S, Termini R, Berioli S, Rizzi CA. Prezioso D, et al. Among authors: scarpa rm. Eur Urol. 2001;40 Suppl 1:2-4. doi: 10.1159/000049869. Eur Urol. 2001. PMID: 11598345

4

BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial.

Colli E, Rigatti P, Montorsi F, Artibani W, Petta S, Mondaini N, Scarpa R, Usai P, Olivieri L, Maggi M; BPH Italian study group. Colli E, et al. Eur Urol. 2006 Jan;49(1):82-6. doi: 10.1016/j.eururo.2005.08.014. Epub 2005 Nov 15. Eur Urol. 2006. PMID: 16310924 Clinical Trial.

5

Urodynamic changes in benign prostatic hyperplasia patients treated by transurethral microwave thermotherapy.

Porru D, Scarpa RM, Delisa A, Usai E. Porru D, et al. Among authors: scarpa rm. Eur Urol. 1994;26(4):303-8. doi: 10.1159/000475404. Eur Urol. 1994. PMID: 7536158 Clinical Trial.

6

Benign prostatic hyperplasia: associated pathology.

Usai E, Scarpa RM, De Lisa A, Porru D. Usai E, et al. Among authors: scarpa rm. J Urol (Paris). 1995;101(1):53-4. J Urol (Paris). 1995. PMID: 7545732 No abstract available.

7

Large benign prostatic hyperplasia means impossible ureteroscopy: myth or reality?

Scarpa RM, De Lisa A, Porru D, Usai E. Scarpa RM, et al. Eur Urol. 2000 Apr;37(4):381-5. doi: 10.1159/000020182. Eur Urol. 2000. PMID: 10765066

8

Transurethral electrovaporization of the prostate in benign prostatic hyperplasia. Evaluation of results using different urodynamic parameters.

Porru D, Scarpa RM, Campus G, Delisa A, Montisci I, Usai E. Porru D, et al. Among authors: scarpa rm. Scand J Urol Nephrol. 1998 Apr;32(2):123-6. doi: 10.1080/003655998750014503. Scand J Urol Nephrol. 1998. PMID: 9606785 Clinical Trial.

9

Urinary symptoms in women with gynecological disorders: the role of symptom evaluation and home uroflowmetry.

Porru D, Scarpa RM, Onnis P, Lavra S, Delisa A, Usai E. Porru D, et al. Among authors: scarpa rm. Arch Esp Urol. 1998 Oct;51(8):843-8. Arch Esp Urol. 1998. PMID: 9859594

10

Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid.

Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E. Porru D, et al. Among authors: scarpa rm. Urol Int. 1997;59(1):26-9. doi: 10.1159/000283012. Urol Int. 1997. PMID: 9313320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters